researchers designed a novel bispecific antibody, CoV2-biRN5, by combining two monoclonal antibodies, C1596 and C952. One ...

Global Bispecific Trispecific Antibodies Market Size Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, April 04, ...

The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma. ScienceDaily . Retrieved April 7, 2025 from www.sciencedaily.com / releases / 2025 / 04 ...

For decades, traditional affinity purification platforms like Protein A have been the cornerstone of monoclonal antibody manufacturing. However, the rise of engineered modalities – including ...

Get Your Free Sample Market Report: What are the Growth Drivers for the Hemlibra Market? The increasing prevalence of hemophilia serves as a major driver of Hemlibra market expansion. This genetic ...

an anti-CTLA-4 monoclonal antibody; IBI-323, a novel LAG3/PD-L1 bispecific antibody; IBI-363, a potential PD-1/IL-2 bispecific antibody fusion protein; IBI-343, a recombinant anti-CLDN18.2 ...

an anti-CTLA-4 monoclonal antibody; IBI-323, a novel LAG3/PD-L1 bispecific antibody; IBI-363, a potential PD-1/IL-2 bispecific antibody fusion protein; IBI-343, a recombinant anti-CLDN18.2 ...

while advancing novel treatments such as anti-CD47 monoclonal antibody, antibody drug conjugates ("ADCs") and bispecific ADCs. The company also achieved major milestones in commercialization and ...

IBI363 has demonstrated outstanding efficacy signals in immunotherapy (IO)-naïve melanoma patients across two earlier clinical trials (Phase 1a/ 1b study NCT05460767 and Phase 2 study NCT06081920), ...